Medpage Today on MSN3d
Weekend Warriors and Dementia; Iron Chelation and Alzheimer's; Neuro Drug Costs Rise(JAMA Neurology) The investigational anti-tau antibody bepranemab missed its primary cognitive endpoint in a phase II trial ...
Disclaimer: This article contains mentions of drug abuse. Reader discretion is advised. Barry Keoghan, who has been open ...
The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...
Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...
Six years after his Alzheimer’s diagnosis, 90-year-old Zelik Bocknek (Zel) refuses to slow down — and he believes his active lifestyle is key to keeping his symptoms at bay.
The Times of India on MSN3d
Alzheimer's drug touted as gamechanger could triple risk of dyingNew research reveals that lecanemab, an Alzheimer's drug previously hailed for slowing disease progression, may increase the ...
DUBLIN--(BUSINESS WIRE)--The "Alzheimer's Drugs - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Alzheimer's Drugs is forecast to ...
Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...
The Journal of the Alzheimer’s Association” — has linked the active ingredient in both of these drugs, semaglutide, to ...
In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback